Archives
Research News
advertisement
March 27, 2013
- Faster pharmacokinetics and increased patient acceptance of intradermal insulin delivery using a single hollow microneedle in children and adolescents with type 1 diabetes.
- Circulating Vitamin D Metabolites and Subclinical Atherosclerosis in Type 1 Diabetes.
- Positron emission tomography measured cerebral blood flow and glucose metabolism are decreased in human type 1 diabetes.
- Protein intake in relation to risk of hypertension and microalbuminuria in patients with type 1 diabetes: the EURODIAB Prospective Complications Study.
- Baseline Markers of Inflammation Are Associated With Progression to Macroalbuminuria in Type 1 Diabetic Subjects.
- Factors associated with the presence of glutamic acid decarboxylase and islet antigen-2 autoantibodies in patients with long-standing type 1 diabetes.
- Marked Expansion of Exocrine and Endocrine Pancreas with Incretin Therapy in Humans with increased Exocrine Pancreas Dysplasia and the potential for Glucagon-producing Neuroendocrine Tumors.
March 20, 2013
- Population-based Survey of the Prevalence of Type 1 and Type 2 diabetes in School Children in Philadelphia.
- Addition of exenatide or sitagliptin to insulin in new onset type 1 diabetes: A randomized, open label study.
- Association of the incidence of type 1 diabetes with markers of infection and antibiotic susceptibility at country level. See also Global Rise in Type 1 Diabetes May Be Linked to Reduced Exposure to Pathogens in Early Life.
- Fasting and meal-stimulated residual beta cell function is positively associated with serum concentrations of proinflammatory cytokines and negatively associated with anti-inflammatory and regulatory cytokines in patients with longer term type 1 diabetes.
- Induced autologous stem cell transplantation for treatment of rabbit type 1 diabetes.
- Long-term bisphenol A exposure accelerates insulitis development in diabetes-prone NOD mice.
March 13, 2013
- Can C-peptide mediated anti-inflammatory effects retard the development of microvascular complications of type 1 diabetes?
- In type 1 diabetes a subset of anti-coxsackievirus b4 antibodies recognize autoantigens and induce apoptosis of pancreatic Beta cells. Free full text available in HTML and PDF formats (link on HTML full text page).
- Maintaining functional islets through encapsulation in an injectable saccharide-peptide hydrogel.
- The Association between IgG4 Antibodies to Dietary Factors, Islet Autoimmunity and Type 1 Diabetes: The Diabetes Autoimmunity Study in the Young. Free full text available in HTML and PDF formats (link on HTML full text page).
- Glucose tolerance and beta-cell function in islet autoantibody-positive children recruited to a secondary prevention study.
March 6, 2013
- Nocturnal Glucose Control with an Artificial Pancreas at a Diabetes Camp. See also Artificial Pancreas Worked Overnight on Kids With Type 1 Diabetes.
- Overnight automated type 1 diabetes control under MD-logic closed-loop system: a randomized crossover trial.
- Does farm environment protect against type 1 diabetes mellitus? Free full text available in HTML and PDF formats.
- Identification of a SIRT1 Mutation in a Family with Type 1 Diabetes. See also First single gene mutation shown to result in type 1 diabetes and First Single Gene Mutation Shown to Result in Type 1 Diabetes.
- Treatment of diabetes mellitus with microencapsulated fetal human liver (FH-B-TPN) engineered cells.
- The Relationship of Sugar to Population-Level Diabetes Prevalence: An Econometric Analysis of Repeated Cross-Sectional Data explores the impact of exposure to sugar on the risk of type 2 diabetes — still quite relevant to anyone with type 1 diabetes. See also Study: Sugar � Not Obesity � Causes Diabetes and Sugar In Diet Linked To Type 2 Diabetes Rates, Study Finds.
- The Diabetes Research Institute announced the DRI BioHub, an artificial organ platform designed to protect islets and provide euglycemia without whole-body immunosuppression, as is required by traditional islet transplants. This announcement of this effort generated heated discussion throughout the online community, not all of it positive. For more, see the following:
- This Could Be It…. What We Have Been Waiting For Since Diagnosis!!!!
- A Message from Diabetes Dad.
- Could it be….
- New DRI Mini �BioHub� Organ Would Mimic a Healthy Pancreas.
- Hope without hype is all we ask (the one when I wish it started differently).
- Don�t Believe the Hype.
- News from the DRI.
- Our Community.
- My Take on the Hub-bub About the Bio Hub.
- Empathy. Honoring struggle without trite solutions.
- Meanwhile, In Other News….
February 27, 2013
- Gut microbiota in children with type 1 diabetes differs from that in healthy children: a case-control study. Free full text available in PDF format.
- Revisiting the notion of type 1 diabetes being a T-cell-mediated autoimmune disease.
- Immune Therapy and beta-Cell Death in Type 1 Diabetes.
- Reactivation of latent viruses in individuals receiving rituximab for new onset type 1 diabetes.
- Proinsulin/Insulin Autoantibodies Measured With Electrochemiluminescent Assay Are the Earliest Indicator of Prediabetic Islet Autoimmunity .
- More people needed for type 1 diabetes vaccine study.
February 20, 2013
- Allogeneic Bone Marrow Cocultured With Human Islets Significantly Improves Islet Survival and Function In Vivo.
- Human milk can neutralize Coxsackievirus B4 in vitro.
- Promotion of Autoimmune Diabetes by Cereal Diet in the Presence or Absence of Microbes Associated With Gut Immune Activation, Regulatory Imbalance, and Altered Cathelicidin Antimicrobial Peptide.
February 13, 2013
- Treatment of Diabetes and Long-term Survival Following Insulin and Glucokinase Gene Therapy. See also UAB researchers cure type 1 diabetes in dogs, Type 1 Diabetes Cured In Dogs, and Type 1 Diabetes Cured in Dogs, Study Suggests.
- Differences in glucose-stimulated insulin secretion in vitro of islets from human, nonhuman primate, and porcine origin.
- Efficacy and Safety of Insulin Degludec in a Flexible Dosing Regimen vs Insulin Glargine in Patients With Type 1 Diabetes (BEGIN: Flex T1): A 26-Week Randomized, Treat-to-Target Trial With a 26-Week Extension.
- Evidence of Association between Type 1 Diabetes and Exposure to Enterovirus in Cuban Children and Adolescents. Free full text available in PDF format.
- A randomized placebo-controlled trial of alphacalcidol on the preservation of beta cell function in children with recent onset type 1 diabetes.
February 6, 2013
- Glucose-responsive insulin and glucagon delivery (dual-hormone artificial pancreas) in adults with type 1 diabetes: a randomized crossover controlled trial. Free full text available in PDF format.
- Preclinical Serum 25-Hydroxyvitamin D Levels and Risk of Type 1 Diabetes in a Cohort of US Military Personnel. See also �Sunshine vitamin� looks a little brighter.
- HLA Class I and II Alleles are Associated with Microvascular Complications of Type 1 Diabetes.
- PDX1-engineered embryonic stem cell-derived insulin producing cells regulate hyperglycemia in diabetic mice. Free full text available in HTML and PDF formats.
January 30, 2013
- Glucose-responsive insulin and glucagon delivery (dual-hormone artificial pancreas) in adults with type 1 diabetes: a randomized crossover controlled trial. Free full text available in PDF format. See also Artificial pancreas: the way of the future for treating type 1 diabetes.
- Promotion of autoimmune diabetes by cereal diet in the presence or absence of microbes associated with gut immune activation, regulatory imbalance and altered cathelicidin antimicrobial peptide .
- Verification of Skin Autofluorescence Values by Mass Spectrometry in Adolescents with Type 1 Diabetes: Brief Report.
- Previous maternal infection protects offspring from enterovirus infection and prevents experimental diabetes development in mice.
advertisement
